These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 32156809)

  • 41. Immunogenicity in mice and non-human primates of the Group A Streptococcal J8 peptide vaccine candidate conjugated to CRM197.
    Caro-Aguilar I; Ottinger E; Hepler RW; Nahas DD; Wu C; Good MF; Batzloff M; Joyce JG; Heinrichs JH; Skinner JM
    Hum Vaccin Immunother; 2013 Mar; 9(3):488-96. PubMed ID: 23249976
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Protection against group A streptococcus by immunization with J8-diphtheria toxoid: contribution of J8- and diphtheria toxoid-specific antibodies to protection.
    Batzloff MR; Hayman WA; Davies MR; Zeng M; Pruksakorn S; Brandt ER; Good MF
    J Infect Dis; 2003 May; 187(10):1598-608. PubMed ID: 12721940
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Enhanced protection against Streptococcus pyogenes infection by intranasal vaccination with a dual antigen component M protein/SfbI lipid core peptide vaccine formulation.
    Olive C; Schulze K; Sun HK; Ebensen T; Horváth A; Toth I; Guzman CA
    Vaccine; 2007 Feb; 25(10):1789-97. PubMed ID: 17229503
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Protective efficacy induced by DNA prime and recombinant protein boost vaccination with Toxoplasma gondii GRA14 in mice.
    Pagheh AS; Sarvi S; Gholami S; Asgarian-Omran H; Valadan R; Hassannia H; Ahmadpour E; Fasihi-Ramandie M; Dodangeh S; Hosseni-Khah Z; Daryani A
    Microb Pathog; 2019 Sep; 134():103601. PubMed ID: 31212035
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Novel adjuvant Alum-TLR7 significantly potentiates immune response to glycoconjugate vaccines.
    Buonsanti C; Balocchi C; Harfouche C; Corrente F; Galli Stampino L; Mancini F; Tontini M; Malyala P; Bufali S; Baudner B; De Gregorio E; Valiante NM; O'Hagan DT; Rappuoli R; D'Oro U
    Sci Rep; 2016 Jul; 6():29063. PubMed ID: 27439378
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy of two adjuvants administrated with a novel hydrogen peroxide-inactivated vaccine against Streptococcus agalactiae in Nile tilapia fingerlings.
    Ramos-Espinoza FC; Cueva-Quiroz VA; Yunis-Aguinaga J; Alvarez-Rubio NC; Paganoti de Mello N; Engrácia de Moraes JR
    Fish Shellfish Immunol; 2020 Oct; 105():350-358. PubMed ID: 32717322
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Systemic immunization with streptococcal immunoglobulin-binding protein Sib 35 induces protective immunity against group: a Streptococcus challenge in mice.
    Okamoto S; Tamura Y; Terao Y; Hamada S; Kawabata S
    Vaccine; 2005 Sep; 23(40):4852-9. PubMed ID: 15990202
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Adsorption to aluminum hydroxide promotes the activity of IL-12 as an adjuvant for antibody as well as type 1 cytokine responses to HIV-1 gp120.
    Jankovic D; Caspar P; Zweig M; Garcia-Moll M; Showalter SD; Vogel FR; Sher A
    J Immunol; 1997 Sep; 159(5):2409-17. PubMed ID: 9278332
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Development of a novel mucosal vaccine against strangles by supercritical enhanced atomization spray-drying of Streptococcus equi extracts and evaluation in a mouse model.
    Rodrigues MA; Figueiredo L; Padrela L; Cadete A; Tiago J; Matos HA; Gomes de Azevedo E; Florindo HF; Gonçalves LM; Almeida AJ
    Eur J Pharm Biopharm; 2012 Oct; 82(2):392-400. PubMed ID: 22841882
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The new nano-complex, Hep-c, improves the immunogenicity of the hepatitis B vaccine.
    Fakharzadeh S; Kalanaky S; Hafizi M; Goya MM; Masoumi Z; Namaki S; Shakeri N; Abbasi M; Mahdavi M; Nazaran MH
    Vaccine; 2013 May; 31(22):2591-7. PubMed ID: 23583463
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Protection against Mycobacterium tuberculosis infection offered by a new multistage subunit vaccine correlates with increased number of IFN-γ+ IL-2+ CD4+ and IFN-γ+ CD8+ T cells.
    Wang X; Zhang J; Liang J; Zhang Y; Teng X; Yuan X; Fan X
    PLoS One; 2015; 10(3):e0122560. PubMed ID: 25822536
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Vaccine composition formulated with a novel TLR7-dependent adjuvant induces high and broad protection against Staphylococcus aureus.
    Bagnoli F; Fontana MR; Soldaini E; Mishra RP; Fiaschi L; Cartocci E; Nardi-Dei V; Ruggiero P; Nosari S; De Falco MG; Lofano G; Marchi S; Galletti B; Mariotti P; Bacconi M; Torre A; Maccari S; Scarselli M; Rinaudo CD; Inoshima N; Savino S; Mori E; Rossi-Paccani S; Baudner B; Pallaoro M; Swennen E; Petracca R; Brettoni C; Liberatori S; Norais N; Monaci E; Bubeck Wardenburg J; Schneewind O; O'Hagan DT; Valiante NM; Bensi G; Bertholet S; De Gregorio E; Rappuoli R; Grandi G
    Proc Natl Acad Sci U S A; 2015 Mar; 112(12):3680-5. PubMed ID: 25775551
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Synthetic Toll-Like Receptor 4 (TLR4) and TLR7 Ligands Work Additively via MyD88 To Induce Protective Antiviral Immunity in Mice.
    Goff PH; Hayashi T; He W; Yao S; Cottam HB; Tan GS; Crain B; Krammer F; Messer K; Pu M; Carson DA; Palese P; Corr M
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28724768
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evidence for cyclic diguanylate as a vaccine adjuvant with novel immunostimulatory activities.
    Gray PM; Forrest G; Wisniewski T; Porter G; Freed DC; DeMartino JA; Zaller DM; Guo Z; Leone J; Fu TM; Vora KA
    Cell Immunol; 2012; 278(1-2):113-9. PubMed ID: 23121983
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The potential of adjuvants to improve immune responses against TdaP vaccines: A preclinical evaluation of MF59 and monophosphoryl lipid A.
    Agnolon V; Bruno C; Leuzzi R; Galletti B; D'Oro U; Pizza M; Seubert A; O'Hagan DT; Baudner BC
    Int J Pharm; 2015 Aug; 492(1-2):169-76. PubMed ID: 26149936
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cross-protective effect of a novel multi-antigen-chimeric vaccine against Streptococcus and Staphylococcus aureus infection in mice.
    Yu L; Fan Z; Ma J; Tong C; Song B; Zhu Z; Cui Y
    J Med Microbiol; 2014 Dec; 63(Pt 12):1732-1740. PubMed ID: 25288644
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The effect of adjuvants and delivery systems on Th1, Th2, Th17 and Treg cytokine responses in mice immunized with Mycobacterium tuberculosis-specific proteins.
    Safar HA; Mustafa AS; Amoudy HA; El-Hashim A
    PLoS One; 2020; 15(2):e0228381. PubMed ID: 32027660
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Recombinant outer membrane protein 25c from Brucella abortus induces Th1 and Th2 mediated protection against Brucella abortus infection in mouse model.
    Paul S; Peddayelachagiri BV; Nagaraj S; Kingston JJ; Batra HV
    Mol Immunol; 2018 Jul; 99():9-18. PubMed ID: 29649688
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immunogenic characterization and protection against Streptococcus mutans infection induced by intranasal DNA prime-protein boost immunization.
    Li YH; Huang S; Du M; Bian Z; Chen Z; Fan MW
    Vaccine; 2010 Jul; 28(32):5370-6. PubMed ID: 20573581
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Chlamydia muridarum T-cell antigens formulated with the adjuvant DDA/TDB induce immunity against infection that correlates with a high frequency of gamma interferon (IFN-gamma)/tumor necrosis factor alpha and IFN-gamma/interleukin-17 double-positive CD4+ T cells.
    Yu H; Jiang X; Shen C; Karunakaran KP; Jiang J; Rosin NL; Brunham RC
    Infect Immun; 2010 May; 78(5):2272-82. PubMed ID: 20231405
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.